Amylyx Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AMLX for the last quarter is 88.64 M USD, and it's 18.26% lower compared to the previous quarter. The net income of Q1 24 is -118.79 M USD.